Compare

Up to four compounds, side by side.

Search or pick a starting set. Differences light up so you can spot them fast.

Retatrutide

1 / 4

Peptide

GLP-1 / GIP / Glucagon Triple Agonist

Overview

Summary

Investigational triple-agonist with the largest weight-loss numbers in early trials.

Category

GLP-1 / GIP / Glucagon Triple Agonist

Mechanism

Triple-agonist targeting GLP-1, GIP, and glucagon receptors for additive metabolic effect.

Effects

Top outcomes

Evidence

Emerging

Practical

Half-life

~6 days (estimated)

Administration

subq

Risk

Legal status

research only

Safety

Side-effect profile similar to other GLP-class drugs; long-term data pending.

Try a preset